Global Infant and Child Multiple Vaccine Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Infant and Child Multiple Vaccine Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Infant and Child Multiple Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Pentavalent Vaccine
  • 1.2.3 Quadruple Vaccine
  • 1.2.4 Triple Vaccine
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Infant and Child Multiple Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 12 Months Below
  • 1.3.3 12 Months Above
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Infant and Child Multiple Vaccine Sales Estimates and Forecasts 2018-2029
• 2.2 Global Infant and Child Multiple Vaccine Revenue by Region
  • 2.2.1 Global Infant and Child Multiple Vaccine Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global Infant and Child Multiple Vaccine Revenue by Region (2018-2023)
  • 2.2.3 Global Infant and Child Multiple Vaccine Revenue by Region (2024-2029)
  • 2.2.4 Global Infant and Child Multiple Vaccine Revenue Market Share by Region (2018-2029)
• 2.3 Global Infant and Child Multiple Vaccine Sales Estimates and Forecasts 2018-2029
• 2.4 Global Infant and Child Multiple Vaccine Sales by Region
  • 2.4.1 Global Infant and Child Multiple Vaccine Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global Infant and Child Multiple Vaccine Sales by Region (2018-2023)
  • 2.4.3 Global Infant and Child Multiple Vaccine Sales by Region (2024-2029)
  • 2.4.4 Global Infant and Child Multiple Vaccine Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Infant and Child Multiple Vaccine Sales by Manufacturers
  • 3.1.1 Global Infant and Child Multiple Vaccine Sales by Manufacturers (2018-2023)
  • 3.1.2 Global Infant and Child Multiple Vaccine Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Infant and Child Multiple Vaccine in 2022
• 3.2 Global Infant and Child Multiple Vaccine Revenue by Manufacturers
  • 3.2.1 Global Infant and Child Multiple Vaccine Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global Infant and Child Multiple Vaccine Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 10 and Top 5 Companies by Infant and Child Multiple Vaccine Revenue in 2022
• 3.3 Global Key Players of Infant and Child Multiple Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
• 3.4 Global Infant and Child Multiple Vaccine Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Infant and Child Multiple Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Infant and Child Multiple Vaccine, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Infant and Child Multiple Vaccine, Product Offered and Application
• 3.8 Global Key Manufacturers of Infant and Child Multiple Vaccine, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Infant and Child Multiple Vaccine Sales by Type
  • 4.1.1 Global Infant and Child Multiple Vaccine Historical Sales by Type (2018-2023)
  • 4.1.2 Global Infant and Child Multiple Vaccine Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2029)
• 4.2 Global Infant and Child Multiple Vaccine Revenue by Type
  • 4.2.1 Global Infant and Child Multiple Vaccine Historical Revenue by Type (2018-2023)
  • 4.2.2 Global Infant and Child Multiple Vaccine Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2029)
• 4.3 Global Infant and Child Multiple Vaccine Price by Type
  • 4.3.1 Global Infant and Child Multiple Vaccine Price by Type (2018-2023)
  • 4.3.2 Global Infant and Child Multiple Vaccine Price Forecast by Type (2024-2029)

5 Market Size by Application

• 5.1 Global Infant and Child Multiple Vaccine Sales by Application
  • 5.1.1 Global Infant and Child Multiple Vaccine Historical Sales by Application (2018-2023)
  • 5.1.2 Global Infant and Child Multiple Vaccine Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2029)
• 5.2 Global Infant and Child Multiple Vaccine Revenue by Application
  • 5.2.1 Global Infant and Child Multiple Vaccine Historical Revenue by Application (2018-2023)
  • 5.2.2 Global Infant and Child Multiple Vaccine Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global Infant and Child Multiple Vaccine Revenue Market Share by Application (2018-2029)
• 5.3 Global Infant and Child Multiple Vaccine Price by Application
  • 5.3.1 Global Infant and Child Multiple Vaccine Price by Application (2018-2023)
  • 5.3.2 Global Infant and Child Multiple Vaccine Price Forecast by Application (2024-2029)

6 US & Canada

• 6.1 US & Canada Infant and Child Multiple Vaccine Market Size by Type
  • 6.1.1 US & Canada Infant and Child Multiple Vaccine Sales by Type (2018-2029)
  • 6.1.2 US & Canada Infant and Child Multiple Vaccine Revenue by Type (2018-2029)
• 6.2 US & Canada Infant and Child Multiple Vaccine Market Size by Application
  • 6.2.1 US & Canada Infant and Child Multiple Vaccine Sales by Application (2018-2029)
  • 6.2.2 US & Canada Infant and Child Multiple Vaccine Revenue by Application (2018-2029)
• 6.3 US & Canada Infant and Child Multiple Vaccine Market Size by Country
  • 6.3.1 US & Canada Infant and Child Multiple Vaccine Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada Infant and Child Multiple Vaccine Sales by Country (2018-2029)
  • 6.3.3 US & Canada Infant and Child Multiple Vaccine Revenue by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Infant and Child Multiple Vaccine Market Size by Type
  • 7.1.1 Europe Infant and Child Multiple Vaccine Sales by Type (2018-2029)
  • 7.1.2 Europe Infant and Child Multiple Vaccine Revenue by Type (2018-2029)
• 7.2 Europe Infant and Child Multiple Vaccine Market Size by Application
  • 7.2.1 Europe Infant and Child Multiple Vaccine Sales by Application (2018-2029)
  • 7.2.2 Europe Infant and Child Multiple Vaccine Revenue by Application (2018-2029)
• 7.3 Europe Infant and Child Multiple Vaccine Market Size by Country
  • 7.3.1 Europe Infant and Child Multiple Vaccine Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe Infant and Child Multiple Vaccine Sales by Country (2018-2029)
  • 7.3.3 Europe Infant and Child Multiple Vaccine Revenue by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Infant and Child Multiple Vaccine Market Size
  • 8.1.1 China Infant and Child Multiple Vaccine Sales (2018-2029)
  • 8.1.2 China Infant and Child Multiple Vaccine Revenue (2018-2029)
• 8.2 China Infant and Child Multiple Vaccine Market Size by Application
  • 8.2.1 China Infant and Child Multiple Vaccine Sales by Application (2018-2029)
  • 8.2.2 China Infant and Child Multiple Vaccine Revenue by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia Infant and Child Multiple Vaccine Market Size by Type
  • 9.1.1 Asia Infant and Child Multiple Vaccine Sales by Type (2018-2029)
  • 9.1.2 Asia Infant and Child Multiple Vaccine Revenue by Type (2018-2029)
• 9.2 Asia Infant and Child Multiple Vaccine Market Size by Application
  • 9.2.1 Asia Infant and Child Multiple Vaccine Sales by Application (2018-2029)
  • 9.2.2 Asia Infant and Child Multiple Vaccine Revenue by Application (2018-2029)
• 9.3 Asia Infant and Child Multiple Vaccine Sales by Region
  • 9.3.1 Asia Infant and Child Multiple Vaccine Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Asia Infant and Child Multiple Vaccine Revenue by Region (2018-2029)
  • 9.3.3 Asia Infant and Child Multiple Vaccine Sales by Region (2018-2029)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Infant and Child Multiple Vaccine Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales by Type (2018-2029)
  • 10.1.2 Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue by Type (2018-2029)
• 10.2 Middle East, Africa and Latin America Infant and Child Multiple Vaccine Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales by Application (2018-2029)
  • 10.2.2 Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue by Application (2018-2029)
• 10.3 Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue by Country: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue by Country (2018-2029)
  • 10.3.3 Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales by Country (2018-2029)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Sanofi
  • 11.1.1 Sanofi Company Information
  • 11.1.2 Sanofi Overview
  • 11.1.3 Sanofi Infant and Child Multiple Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 Sanofi Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Sanofi Recent Developments
• 11.2 GSK
  • 11.2.1 GSK Company Information
  • 11.2.2 GSK Overview
  • 11.2.3 GSK Infant and Child Multiple Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 GSK Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 GSK Recent Developments
• 11.3 Mitsubishi Tanabe Pharma
  • 11.3.1 Mitsubishi Tanabe Pharma Company Information
  • 11.3.2 Mitsubishi Tanabe Pharma Overview
  • 11.3.3 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Mitsubishi Tanabe Pharma Recent Developments
• 11.4 KM Biologics
  • 11.4.1 KM Biologics Company Information
  • 11.4.2 KM Biologics Overview
  • 11.4.3 KM Biologics Infant and Child Multiple Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 KM Biologics Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 KM Biologics Recent Developments
• 11.5 Wuhan Institute of Biological Products
  • 11.5.1 Wuhan Institute of Biological Products Company Information
  • 11.5.2 Wuhan Institute of Biological Products Overview
  • 11.5.3 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Wuhan Institute of Biological Products Recent Developments
• 11.6 Walvax Biotechnology
  • 11.6.1 Walvax Biotechnology Company Information
  • 11.6.2 Walvax Biotechnology Overview
  • 11.6.3 Walvax Biotechnology Infant and Child Multiple Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.6.4 Walvax Biotechnology Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Walvax Biotechnology Recent Developments
• 11.7 Chengdu Institute of Biological Products
  • 11.7.1 Chengdu Institute of Biological Products Company Information
  • 11.7.2 Chengdu Institute of Biological Products Overview
  • 11.7.3 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.7.4 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Chengdu Institute of Biological Products Recent Developments
• 11.8 Minhai Biotechnology
  • 11.8.1 Minhai Biotechnology Company Information
  • 11.8.2 Minhai Biotechnology Overview
  • 11.8.3 Minhai Biotechnology Infant and Child Multiple Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.8.4 Minhai Biotechnology Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Minhai Biotechnology Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Infant and Child Multiple Vaccine Industry Chain Analysis
• 12.2 Infant and Child Multiple Vaccine Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Infant and Child Multiple Vaccine Production Mode & Process
• 12.4 Infant and Child Multiple Vaccine Sales and Marketing
  • 12.4.1 Infant and Child Multiple Vaccine Sales Channels
  • 12.4.2 Infant and Child Multiple Vaccine Distributors
• 12.5 Infant and Child Multiple Vaccine Customers

13 Market Dynamics

• 13.1 Infant and Child Multiple Vaccine Industry Trends
• 13.2 Infant and Child Multiple Vaccine Market Drivers
• 13.3 Infant and Child Multiple Vaccine Market Challenges
• 13.4 Infant and Child Multiple Vaccine Market Restraints

14 Key Findings in The Global Infant and Child Multiple Vaccine Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Infant and Child Multiple Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of Pentavalent Vaccine
• Table 3. Major Manufacturers of Quadruple Vaccine
• Table 4. Major Manufacturers of Triple Vaccine
• Table 5. Major Manufacturers of Others
• Table 6. Global Infant and Child Multiple Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 7. Global Infant and Child Multiple Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 8. Global Infant and Child Multiple Vaccine Revenue by Region (2018-2023) & (US$ Million)
• Table 9. Global Infant and Child Multiple Vaccine Revenue by Region (2024-2029) & (US$ Million)
• Table 10. Global Infant and Child Multiple Vaccine Revenue Market Share by Region (2018-2023)
• Table 11. Global Infant and Child Multiple Vaccine Revenue Market Share by Region (2024-2029)
• Table 12. Global Infant and Child Multiple Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 13. Global Infant and Child Multiple Vaccine Sales by Region (2018-2023) & (M Doses)
• Table 14. Global Infant and Child Multiple Vaccine Sales by Region (2024-2029) & (M Doses)
• Table 15. Global Infant and Child Multiple Vaccine Sales Market Share by Region (2018-2023)
• Table 16. Global Infant and Child Multiple Vaccine Sales Market Share by Region (2024-2029)
• Table 17. Global Infant and Child Multiple Vaccine Sales by Manufacturers (2018-2023) & (M Doses)
• Table 18. Global Infant and Child Multiple Vaccine Sales Share by Manufacturers (2018-2023)
• Table 19. Global Infant and Child Multiple Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 20. Global Infant and Child Multiple Vaccine Revenue Share by Manufacturers (2018-2023)
• Table 21. Global Key Players of Infant and Child Multiple Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
• Table 22. Infant and Child Multiple Vaccine Price by Manufacturers 2018-2023 (US$/Dose)
• Table 23. Global Infant and Child Multiple Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 24. Global Infant and Child Multiple Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infant and Child Multiple Vaccine as of 2022)
• Table 25. Global Key Manufacturers of Infant and Child Multiple Vaccine, Manufacturing Base Distribution and Headquarters
• Table 26. Global Key Manufacturers of Infant and Child Multiple Vaccine, Product Offered and Application
• Table 27. Global Key Manufacturers of Infant and Child Multiple Vaccine, Date of Enter into This Industry
• Table 28. Mergers & Acquisitions, Expansion Plans
• Table 29. Global Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
• Table 30. Global Infant and Child Multiple Vaccine Sales by Type (2024-2029) & (M Doses)
• Table 31. Global Infant and Child Multiple Vaccine Sales Share by Type (2018-2023)
• Table 32. Global Infant and Child Multiple Vaccine Sales Share by Type (2024-2029)
• Table 33. Global Infant and Child Multiple Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 34. Global Infant and Child Multiple Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 35. Global Infant and Child Multiple Vaccine Revenue Share by Type (2018-2023)
• Table 36. Global Infant and Child Multiple Vaccine Revenue Share by Type (2024-2029)
• Table 37. Infant and Child Multiple Vaccine Price by Type (2018-2023) & (US$/Dose)
• Table 38. Global Infant and Child Multiple Vaccine Price Forecast by Type (2024-2029) & (US$/Dose)
• Table 39. Global Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
• Table 40. Global Infant and Child Multiple Vaccine Sales by Application (2024-2029) & (M Doses)
• Table 41. Global Infant and Child Multiple Vaccine Sales Share by Application (2018-2023)
• Table 42. Global Infant and Child Multiple Vaccine Sales Share by Application (2024-2029)
• Table 43. Global Infant and Child Multiple Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 44. Global Infant and Child Multiple Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 45. Global Infant and Child Multiple Vaccine Revenue Share by Application (2018-2023)
• Table 46. Global Infant and Child Multiple Vaccine Revenue Share by Application (2024-2029)
• Table 47. Infant and Child Multiple Vaccine Price by Application (2018-2023) & (US$/Dose)
• Table 48. Global Infant and Child Multiple Vaccine Price Forecast by Application (2024-2029) & (US$/Dose)
• Table 49. US & Canada Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
• Table 50. US & Canada Infant and Child Multiple Vaccine Sales by Type (2024-2029) & (M Doses)
• Table 51. US & Canada Infant and Child Multiple Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 52. US & Canada Infant and Child Multiple Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 53. US & Canada Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
• Table 54. US & Canada Infant and Child Multiple Vaccine Sales by Application (2024-2029) & (M Doses)
• Table 55. US & Canada Infant and Child Multiple Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 56. US & Canada Infant and Child Multiple Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 57. US & Canada Infant and Child Multiple Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 58. US & Canada Infant and Child Multiple Vaccine Revenue by Country (2018-2023) & (US$ Million)
• Table 59. US & Canada Infant and Child Multiple Vaccine Revenue by Country (2024-2029) & (US$ Million)
• Table 60. US & Canada Infant and Child Multiple Vaccine Sales by Country (2018-2023) & (M Doses)
• Table 61. US & Canada Infant and Child Multiple Vaccine Sales by Country (2024-2029) & (M Doses)
• Table 62. Europe Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
• Table 63. Europe Infant and Child Multiple Vaccine Sales by Type (2024-2029) & (M Doses)
• Table 64. Europe Infant and Child Multiple Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 65. Europe Infant and Child Multiple Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 66. Europe Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
• Table 67. Europe Infant and Child Multiple Vaccine Sales by Application (2024-2029) & (M Doses)
• Table 68. Europe Infant and Child Multiple Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 69. Europe Infant and Child Multiple Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 70. Europe Infant and Child Multiple Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 71. Europe Infant and Child Multiple Vaccine Revenue by Country (2018-2023) & (US$ Million)
• Table 72. Europe Infant and Child Multiple Vaccine Revenue by Country (2024-2029) & (US$ Million)
• Table 73. Europe Infant and Child Multiple Vaccine Sales by Country (2018-2023) & (M Doses)
• Table 74. Europe Infant and Child Multiple Vaccine Sales by Country (2024-2029) & (M Doses)
• Table 75. China Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
• Table 76. China Infant and Child Multiple Vaccine Sales by Type (2024-2029) & (M Doses)
• Table 77. China Infant and Child Multiple Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 78. China Infant and Child Multiple Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 79. China Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
• Table 80. China Infant and Child Multiple Vaccine Sales by Application (2024-2029) & (M Doses)
• Table 81. China Infant and Child Multiple Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 82. China Infant and Child Multiple Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 83. Asia Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
• Table 84. Asia Infant and Child Multiple Vaccine Sales by Type (2024-2029) & (M Doses)
• Table 85. Asia Infant and Child Multiple Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 86. Asia Infant and Child Multiple Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 87. Asia Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
• Table 88. Asia Infant and Child Multiple Vaccine Sales by Application (2024-2029) & (M Doses)
• Table 89. Asia Infant and Child Multiple Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 90. Asia Infant and Child Multiple Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 91. Asia Infant and Child Multiple Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 92. Asia Infant and Child Multiple Vaccine Revenue by Region (2018-2023) & (US$ Million)
• Table 93. Asia Infant and Child Multiple Vaccine Revenue by Region (2024-2029) & (US$ Million)
• Table 94. Asia Infant and Child Multiple Vaccine Sales by Region (2018-2023) & (M Doses)
• Table 95. Asia Infant and Child Multiple Vaccine Sales by Region (2024-2029) & (M Doses)
• Table 96. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
• Table 97. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales by Type (2024-2029) & (M Doses)
• Table 98. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 99. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 100. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
• Table 101. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales by Application (2024-2029) & (M Doses)
• Table 102. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 103. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 104. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 105. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue by Country (2018-2023) & (US$ Million)
• Table 106. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue by Country (2024-2029) & (US$ Million)
• Table 107. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales by Country (2018-2023) & (M Doses)
• Table 108. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales by Country (2024-2029) & (M Doses)
• Table 109. Sanofi Company Information
• Table 110. Sanofi Description and Major Businesses
• Table 111. Sanofi Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
• Table 112. Sanofi Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 113. Sanofi Recent Developments
• Table 114. GSK Company Information
• Table 115. GSK Description and Major Businesses
• Table 116. GSK Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
• Table 117. GSK Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 118. GSK Recent Developments
• Table 119. Mitsubishi Tanabe Pharma Company Information
• Table 120. Mitsubishi Tanabe Pharma Description and Major Businesses
• Table 121. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
• Table 122. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 123. Mitsubishi Tanabe Pharma Recent Developments
• Table 124. KM Biologics Company Information
• Table 125. KM Biologics Description and Major Businesses
• Table 126. KM Biologics Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
• Table 127. KM Biologics Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 128. KM Biologics Recent Developments
• Table 129. Wuhan Institute of Biological Products Company Information
• Table 130. Wuhan Institute of Biological Products Description and Major Businesses
• Table 131. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
• Table 132. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 133. Wuhan Institute of Biological Products Recent Developments
• Table 134. Walvax Biotechnology Company Information
• Table 135. Walvax Biotechnology Description and Major Businesses
• Table 136. Walvax Biotechnology Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
• Table 137. Walvax Biotechnology Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 138. Walvax Biotechnology Recent Developments
• Table 139. Chengdu Institute of Biological Products Company Information
• Table 140. Chengdu Institute of Biological Products Description and Major Businesses
• Table 141. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
• Table 142. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 143. Chengdu Institute of Biological Products Recent Developments
• Table 144. Minhai Biotechnology Company Information
• Table 145. Minhai Biotechnology Description and Major Businesses
• Table 146. Minhai Biotechnology Infant and Child Multiple Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
• Table 147. Minhai Biotechnology Infant and Child Multiple Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 148. Minhai Biotechnology Recent Developments
• Table 149. Key Raw Materials Lists
• Table 150. Raw Materials Key Suppliers Lists
• Table 151. Infant and Child Multiple Vaccine Distributors List
• Table 152. Infant and Child Multiple Vaccine Customers List
• Table 153. Infant and Child Multiple Vaccine Market Trends
• Table 154. Infant and Child Multiple Vaccine Market Drivers
• Table 155. Infant and Child Multiple Vaccine Market Challenges
• Table 156. Infant and Child Multiple Vaccine Market Restraints
• Table 157. Research Programs/Design for This Report
• Table 158. Key Data Information from Secondary Sources
• Table 159. Key Data Information from Primary Sources

List of Figures

• Figure 1. Infant and Child Multiple Vaccine Product Picture
• Figure 2. Global Infant and Child Multiple Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Infant and Child Multiple Vaccine Market Share by Type in 2022 & 2029
• Figure 4. Pentavalent Vaccine Product Picture
• Figure 5. Quadruple Vaccine Product Picture
• Figure 6. Triple Vaccine Product Picture
• Figure 7. Others Product Picture
• Figure 8. Global Infant and Child Multiple Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 9. Global Infant and Child Multiple Vaccine Market Share by Application in 2022 & 2029
• Figure 10. 12 Months Below
• Figure 11. 12 Months Above
• Figure 12. Infant and Child Multiple Vaccine Report Years Considered
• Figure 13. Global Infant and Child Multiple Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 14. Global Infant and Child Multiple Vaccine Revenue 2018-2029 (US$ Million)
• Figure 15. Global Infant and Child Multiple Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 16. Global Infant and Child Multiple Vaccine Revenue Market Share by Region (2018-2029)
• Figure 17. Global Infant and Child Multiple Vaccine Sales 2018-2029 ((M Doses)
• Figure 18. Global Infant and Child Multiple Vaccine Sales Market Share by Region (2018-2029)
• Figure 19. US & Canada Infant and Child Multiple Vaccine Sales YoY (2018-2029) & (M Doses)
• Figure 20. US & Canada Infant and Child Multiple Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 21. Europe Infant and Child Multiple Vaccine Sales YoY (2018-2029) & (M Doses)
• Figure 22. Europe Infant and Child Multiple Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 23. China Infant and Child Multiple Vaccine Sales YoY (2018-2029) & (M Doses)
• Figure 24. China Infant and Child Multiple Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 25. Asia (excluding China) Infant and Child Multiple Vaccine Sales YoY (2018-2029) & (M Doses)
• Figure 26. Asia (excluding China) Infant and Child Multiple Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 27. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales YoY (2018-2029) & (M Doses)
• Figure 28. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 29. The Infant and Child Multiple Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 30. The Top 5 and 10 Largest Manufacturers of Infant and Child Multiple Vaccine in the World: Market Share by Infant and Child Multiple Vaccine Revenue in 2022
• Figure 31. Global Infant and Child Multiple Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 32. Global Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2029)
• Figure 33. Global Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2029)
• Figure 34. Global Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2029)
• Figure 35. Global Infant and Child Multiple Vaccine Revenue Market Share by Application (2018-2029)
• Figure 36. US & Canada Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2029)
• Figure 37. US & Canada Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2029)
• Figure 38. US & Canada Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2029)
• Figure 39. US & Canada Infant and Child Multiple Vaccine Revenue Market Share by Application (2018-2029)
• Figure 40. US & Canada Infant and Child Multiple Vaccine Revenue Share by Country (2018-2029)
• Figure 41. US & Canada Infant and Child Multiple Vaccine Sales Share by Country (2018-2029)
• Figure 42. U.S. Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 43. Canada Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 44. Europe Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2029)
• Figure 45. Europe Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2029)
• Figure 46. Europe Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2029)
• Figure 47. Europe Infant and Child Multiple Vaccine Revenue Market Share by Application (2018-2029)
• Figure 48. Europe Infant and Child Multiple Vaccine Revenue Share by Country (2018-2029)
• Figure 49. Europe Infant and Child Multiple Vaccine Sales Share by Country (2018-2029)
• Figure 50. Germany Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 51. France Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 52. U.K. Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 53. Italy Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 54. Russia Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 55. China Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2029)
• Figure 56. China Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2029)
• Figure 57. China Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2029)
• Figure 58. China Infant and Child Multiple Vaccine Revenue Market Share by Application (2018-2029)
• Figure 59. Asia Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2029)
• Figure 60. Asia Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2029)
• Figure 61. Asia Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2029)
• Figure 62. Asia Infant and Child Multiple Vaccine Revenue Market Share by Application (2018-2029)
• Figure 63. Asia Infant and Child Multiple Vaccine Revenue Share by Region (2018-2029)
• Figure 64. Asia Infant and Child Multiple Vaccine Sales Share by Region (2018-2029)
• Figure 65. Japan Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 66. South Korea Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 67. China Taiwan Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 68. Southeast Asia Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 69. India Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 70. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2029)
• Figure 71. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2029)
• Figure 72. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2029)
• Figure 73. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue Market Share by Application (2018-2029)
• Figure 74. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Revenue Share by Country (2018-2029)
• Figure 75. Middle East, Africa and Latin America Infant and Child Multiple Vaccine Sales Share by Country (2018-2029)
• Figure 76. Brazil Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 77. Mexico Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 78. Turkey Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 79. Israel Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 80. GCC Countries Infant and Child Multiple Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 81. Infant and Child Multiple Vaccine Value Chain
• Figure 82. Infant and Child Multiple Vaccine Production Process
• Figure 83. Channels of Distribution
• Figure 84. Distributors Profiles
• Figure 85. Bottom-up and Top-down Approaches for This Report
• Figure 86. Data Triangulation
• Figure 87. Key Executives Interviewed